According to the results, 11C-PD153035 PET/CT was a promising tool for EGFR-targeted molecular imaging of GBM, which could translate into clinical applications to select patients suitable for EGFR-targeted therapies and to assess the early response of malignant gliomas to such therapies (108). The gene discussed is EGFR; the disease is glioblastoma.